Mandate

Vinge advises Litorina V in connection with the acquisition of Sushi Yama

Sushi Yama is a leading sushi restaurant chain with over 45 restaurants in Sweden.

Sushi Yama was the first chain in the Nordics to certify all its restaurants to serve ASC and MSC certified products to its customers. Thanks to the partnership, Sushi Yama can now accelerate its expansion in Sweden and internationally.

Vinge’s team consisted of Jonas Johansson together with, among others, Carl Sander, Christina Odengran and Ellinor Wargenbrant (M&A), Karolina Cohrs and Frida Ställborn (Real estate), Cornelia Medrek and Olof Löfvenberg (Environment), Victoria Ribbnäs and Axel Jansson (Banking and Finance), Ebba Svenburg (Employment), Agnes Perbo and Lova Unge (Commercial Agreements), Ilze Lukins (IP), Johan Wahlbom (Competition law) and VDR-specialist Viktoria Owetz Leyva.

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026